StreetInsider.com News Articles

LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026

Fri, 18 Sep 2026 08:00:00 -0400

SALT LAKE CITY, Sept. 18, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Terrence Moorehead, Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the upcoming WTR Virtual Insights Conference on Wednesday, September 23, 2026.

The webcast of the presentation will begin at approximately 1:30 p.m. Eastern Time on Wednesday, September 23, 2026. The event is open access for all investors and interested parties can register through the Company’s Investor Relations

LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026

Fri, 18 Sep 2026 08:00:00 -0400

Form 4 Lifevantage Corp For: Sep 15 Filed by: Lewis Darwin

Thu, 17 Sep 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260917/27075826.html

Form 4 Lifevantage Corp For: Sep 10 Filed by: Cunningham Kristen

Mon, 14 Sep 2026 18:56:00 -0400

si-local-file:///var/storage/secattach/20260914/27059665.html

Form 4 Lifevantage Corp For: Sep 10 Filed by: Aure Carl

Mon, 14 Sep 2026 18:56:00 -0400

si-local-file:///var/storage/secattach/20260914/27059666.html

Lifevantage Corporation (LFVN) PT Raised to $6 at Lake Street

Fri, 28 Aug 2026 09:25:03 -0400

Lake Street analyst Ryan M raised the price target on Lifevantage Corporation (NASDAQ: LFVN) to $6.00 (from $5.00) while maintaining a Hold rating.

Lifevantage (LFVN) Misses Q4 EPS by 2c

Thu, 27 Aug 2026 16:06:18 -0400

Lifevantage (NASDAQ: LFVN) reported Q4 EPS of $0.11, $0.02 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $42.37 million versus the consensus estimate of $44.37 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.

Form 10-K Lifevantage Corp For: Jun 30

Thu, 27 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260827/26989857.html

Form 10-K Lifevantage Corp For: Jun 30

Thu, 27 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260827/26989857.html

Form 8-K Lifevantage Corp For: Aug 27

Thu, 27 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260827/26989865.html

Form 8-K Lifevantage Corp For: Aug 27

Thu, 27 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260827/26989865.html

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

Thu, 27 Aug 2026 16:05:00 -0400

SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth fiscal quarter ended June 30, 2026.

Fourth Quarter Fiscal 2026 Summary*:

Revenue was $42.4 million, a decrease of 23.1% from the prior year period;
Revenue in the Americas decreased 24.8%, and revenue in Asia/Pacific & Europe decreased 16.9%;
Net income per diluted share was $0.10, versus $0.15 per diluted share

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

Thu, 27 Aug 2026 16:05:00 -0400

Fourth Quarter Fiscal 2026 Summary*:

Revenue was $42.4 million, a decrease of 23.1% from the prior year period;
Revenue in the Americas decreased 24.8%, and revenue in Asia/Pacific & Europe decreased 16.9%;
Net income per diluted share was $0.10, versus $0.15 per diluted share

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

Thu, 27 Aug 2026 16:05:00 -0400

Fourth Quarter Fiscal 2026 Summary*:

Revenue was $42.4 million, a decrease of 23.1% from the prior year period;
Revenue in the Americas decreased 24.8%, and revenue in Asia/Pacific & Europe decreased 16.9%;
Net income per diluted share was $0.10, versus $0.15 per diluted share

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

Thu, 27 Aug 2026 16:05:00 -0400

Fourth Quarter Fiscal 2026 Summary*:

Revenue was $42.4 million, a decrease of 23.1% from the prior year period;
Revenue in the Americas decreased 24.8%, and revenue in Asia/Pacific & Europe decreased 16.9%;
Net income per diluted share was $0.10, versus $0.15 per diluted share

Lifevantage (LFVN) Declares $0.050 Quarterly Dividend; 3% Yield

Fri, 21 Aug 2026 08:01:20 -0400

Lifevantage (NASDAQ: LFVN) declared a quarterly dividend of $0.050 per share, or $0.2 annualized.

The dividend will be payable on September 15, 2026, to stockholders of record on September 1, 2026, with an ex-dividend date of August 31, 2026.

The annual yield on the dividend is 3 percent.

For a dividend history and other dividend-related data on Lifevantage (LFVN) click here.

LifeVantage Declares Quarterly Dividend

Fri, 21 Aug 2026 08:00:00 -0400

SALT LAKE CITY, Aug. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid September 15, 2026 to all stockholders of record at the close of business on September 1, 2026.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring

LifeVantage Declares Quarterly Dividend

Fri, 21 Aug 2026 08:00:00 -0400

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring

LifeVantage Declares Quarterly Dividend

Fri, 21 Aug 2026 08:00:00 -0400

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring

LifeVantage Declares Quarterly Dividend

Fri, 21 Aug 2026 08:00:00 -0400

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026

Thu, 13 Aug 2026 16:30:00 -0400

SALT LAKE CITY, Aug. 13, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2026, after the stock market closes on Thursday, August 27, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

Investors interested in participating in the live call can dial (877) 704-4453 from the

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026

Thu, 13 Aug 2026 16:30:00 -0400

Investors interested in participating in the live call can dial (877) 704-4453 from the

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026

Thu, 13 Aug 2026 16:30:00 -0400

Investors interested in participating in the live call can dial (877) 704-4453 from the

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026

Thu, 13 Aug 2026 16:30:00 -0400

Investors interested in participating in the live call can dial (877) 704-4453 from the

Form SCHEDULE 13G/A Lifevantage Corp Filed by: RENAISSANCE TECHNOLOGIES LLC

Thu, 13 Aug 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260813/26921645.html